We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 5,100

Proposed Amendments to Regulations Define Health Care Institutions’ Pharmaceutical and Medical Device Adverse Event Reporting Obligations
  • McCarthy Tétrault LLP
  • Canada
  • June 21 2018

In November 2014, the Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law) came into force, amending the Food and Drugs Act to include


CCPC Confirms that Irish Pharmaceutical Sector Under Review Following Pricing Concerns
  • Matheson
  • Ireland
  • June 19 2018

There have been reports in PaRR today that a spokesperson for the Competition and Consumer Protection Commission (“CCPC”) in Ireland has confirmed


Pharmaceuticals and Brexit: Keeping the industry healthy
  • Linklaters LLP
  • United Kingdom, European Union
  • June 19 2018

It is estimated that each month 37 million packs of medicines are supplied from European countries to the UK with 45 million heading in the other


California and Nevada Agencies Move Ahead with Drug Price Transparency Rule Making
  • Arent Fox LLP
  • USA
  • June 7 2018

The California Office of Statewide Health Planning and Development (OSHPD) has posted a preliminary working draft of the regulations implementing


Connecticut and Maine Become the Latest States to Adopt New Drug Pricing Transparency Laws
  • Arent Fox LLP
  • USA
  • June 6 2018

Connecticut and Maine recently joined the increasing number of states to enact drug price transparency laws. Maine’s drug price transparency law (the


High Court of Australia Settles Principles for Preliminary Discovery
  • Jones Day
  • Australia
  • June 5 2018

Pfizer manufactures and supplies the biological medicine Enbrel (etanercept), used in the treatment of autoimmune diseases. Pfizer brought an


Life Sciences: product regulation and liability in Denmark
  • Accura Advokatpartnerselskab
  • Denmark, Global
  • June 1 2018

A structured guide to product regulation and liability laws in Denmark


Federal Court in Illinois Holds Insurer Must Cover Costs of Responding to DOJ Subpoena in a Health Care Fraud Investigation
  • Reed Smith LLP
  • USA
  • June 1 2018

A U.S. District Judge recently ruled in favor of a pharmaceutical manufacturer policyholder against its insurers regarding claims for the costs of


Orphan medicines. The European Commission updates the definition of 'similar medicinal product'
  • De Berti Jacchia Franchini Forlani Studio Legale
  • European Union
  • June 1 2018

The continuous advance in scientific research and technical knowledge in the pharmaceutical industry make it very important to put in place continuous


Life Sciences: product regulation and liability in France
  • Reed Smith LLP
  • France, Global
  • May 29 2018

A structured guide to product regulation and liability laws in France